NCT00144248 - A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 25, 2004

Primary Completion Date

June 1, 2006

Conditions

HIV InfectionsHepatic Insufficiency

Interventions

DRUG

nevirapine

Trial Locations (8)

Boehringer Ingelheim Investigational Site, Bakersfield

Boehringer Ingelheim Investigational Site, San Francisco

California Pacific Medical Center, San Francisco

Albany Medical College, MC 142, Albany

Boehringer Ingelheim Investigational Site, Providence

Hopital de l'Hotel Dieu, Lyon

Hopital Pitie Salpetriere, Paris

Hospital Clinico y Provincial de Barcelona - HIV, Barcelona